Healthy volunteers needed to test new myelofibrosis drug's absorption
NCT ID NCT07492355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well two different capsule forms of TP-3654 are absorbed by the body and whether taking them with food changes absorption. It involved 24 healthy adults and was completed. The results will help design future studies for people with myelofibrosis, a bone marrow disorder.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical
Secaucus, New Jersey, 07094, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.